CF cystic fibrosis COPD chronic obstructive pulmonary disease EFS electrical field stimulation FDA Food and Drug Adminstration FEV1 forced expiratory volume in1 second LPS lipopolysaccharide PDE phosphodiesterase 1 INTRODUCTION Current treatment of patients with asthma or chronic obstructive pulmonary disease (COPD) predominantly involves the use of inhaled bronchodilators (β2-adrenoceptor agonists and muscarinic receptor antagonists)(Matera et al., 2020) and anti-inflammatory corticosteroids...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Clive
Contact Clive, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack